JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141331

Clofibrate, PPARalpha agonist

Be the first to review this product! 리뷰 제출

|

(0 출판물)

MW 242.7 Da, Purity >99%. PPARα agonist (EC50 values are 50 and 55 μM at mouse and human receptors respectively). Antihyperlipoproteinemic agent.

대체 명칭 보기

1,8-cineole 2-exo-monooxygenase, Albendazole monooxygenase, Albendazole sulfoxidase, Atherosclerosis, susceptibility to, included, CP33, CP34, CP3A4_HUMAN, CYP3, CYP3A, CYP3A3, CYP3A4, CYPIIIA3, CYPIIIA4, Cytochrome P450 3A3, Cytochrome P450 3A4, Cytochrome P450 HLp, Cytochrome P450 NF-25, Cytochrome P450 family 3 subfamily A polypeptide 4, Cytochrome P450 subfamily IIIA polypeptide 4, Cytochrome P450-PCN1, DKFZp686N23123, ER, ER-alpha, ER-beta, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESTR B, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen resistance, included, FABP 1, FABPL_HUMAN, Fatty acid binding protein 1 liver, Fatty acid-binding protein, Fatty acid-binding protein 1, Fatty acid-binding protein liver, Glucocorticoid inducible P450, HDL cholesterol, augmented response of, to hormone replacement, included, HLP, L-FABP, Liver-type fatty acid-binding protein, MGC126680, Myocardial infarction, susceptibility to, included, NF 25, NR3A1, NR3A2, Nifedipine oxidase, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, OTTHUMP00000017718, OTTHUMP00000017719, P450 III steroid inducible, P450 PCN1, P450, family III, P450C3, Quinine 3-monooxygenase, RNESTROR, Taurochenodeoxycholate 6-alpha-hydroxylase, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 3, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4

1 이미지
Chemical Structure - Clofibrate, PPARalpha agonist (AB141331)
  • Chemical Structure

Lab

Chemical Structure - Clofibrate, PPARalpha agonist (AB141331)

2D chemical structure image of ab141331, Clofibrate, PPARalpha agonist

주요 정보

CAS 번호

637-07-0

Purity

>99%

제형

Liquid

form

Molecular weight

242.7 Da

Molecular formula

C<sub>1</sub><sub>2</sub>H<sub>1</sub><sub>5</sub>ClO<sub>3</sub>

PubChem

2796

Nature

Synthetic

생화학적 명칭

Clofibrate

생물학적 정보

PPARα agonist (EC50 values are 50 and 55 μM at mouse and human receptors respectively). Antihyperlipoproteinemic agent.

Canonical SMILES

CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl

InChi

InChI=1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3

InChiKey

KNHUKKLJHYUCFP-UHFFFAOYSA-N

IUPAC Name

ethyl 2-(4-chlorophenoxy)-2-methylpropanoate

제품 세부 정보

ab141331 is a colorless liquid at room temperature with a density of approximately 1.1 g/mL.

특성 및 보관 정보

배송 시 보관 조건
Ambient - Can Ship with Ice
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
+4°C
취급 방법

Need more advice on solubility, usage and handling? Please visit our our product support page for more details.

|

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

|

Refer to SDS for further information.

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

The Estrogen Receptor Cytochrome P450 3A4 (CYP3A4) and liver FABP (Fatty Acid Binding Protein) are important proteins with distinct mechanical roles in the body. The Estrogen Receptor acts as a nuclear hormone receptor regulating gene expression upon estrogen binding. CYP3A4 a member of the cytochrome P450 family is a large enzyme with a mass of approximately 57 kDa and is mainly expressed in the liver. It functions to metabolize various xenobiotics and endogenous compounds. The liver FABP a smaller protein helps bind and transport fatty acids within liver cells.
Biological function summary

The Estrogen Receptor influences reproductive tissues and breast development by regulating genes involved in cell growth. It forms complexes with coactivator proteins to modulate transcription. CYP3A4 participates in the metabolism of drugs and steroids affecting their clearance and bioavailability. Liver FABP assists in the intracellular trafficking of lipids and the modulation of lipid levels within hepatocytes which are liver cells.

Pathways

The Estrogen Receptor plays significant roles in the estrogen signaling pathway which involves proteins like coactivators and corepressors influencing cell proliferation and differentiation. CYP3A4 facilitates the drug metabolism pathway interacting with proteins such as cytochrome P450 reductase. These proteins collaborate to metabolize drugs and regulate endogenous steroid levels. Liver FABP is involved in lipid metabolism pathways working with enzymes that process and transport lipids within the liver.

Estrogen Receptor dysfunction relates to hormone-sensitive cancers such as breast cancer. This receptor's interaction with proteins like HER2 impacts tumor progression and response to therapy. CYP3A4 is associated with drug metabolism disorders leading to altered pharmacokinetics and may affect proteins involved in drug clearance increasing susceptibility to drug toxicity. Liver FABP plays a role in fatty liver disease with its interaction affecting lipid metabolism pathways and gene expression in metabolic disorders.

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com